Drug Pipeline

HRS-6209 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05582499 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study… Breast Neoplasm Recruiting
Phase 1/2
NCT06679036 A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or… Advanced Unresectable or Metastatic Breast Cancer Recruiting
Phase 1
NCT05781048 A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial… Advanced Solid Tumors Active, Not Recruiting
Sponsors Running HRS-6209 Trials
Fudan University (1) Jiangsu HengRui Medicine Co., Ltd. (1) Shandong Suncadia Medicine Co., Ltd. (1)
Disease Areas
Breast Cancer (2) Triple-Negative Breast Cancer (1) HER2-Positive Breast Cancer (1)
Get alerts when HRS-6209 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free